# Study to Evaluate the Safety of the Viscoelastic Substance PRO-149, Compared to Healon® EndoCoat.

> **NCT04702802** · NA · COMPLETED · sponsor: **Laboratorios Sophia S.A de C.V.** · enrollment: 36 (actual)

## Conditions studied

- Age-related Cataract
- Phacoemulsification

## Interventions

- **DEVICE:** Sodium hyaluronate 3%
- **DEVICE:** Sodium hyaluronate 3%

## Key facts

- **NCT ID:** NCT04702802
- **Lead sponsor:** Laboratorios Sophia S.A de C.V.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-07
- **Primary completion:** 2021-10-29
- **Final completion:** 2021-10-29
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2025-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04702802

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04702802, "Study to Evaluate the Safety of the Viscoelastic Substance PRO-149, Compared to Healon® EndoCoat.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04702802. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*